Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for Asymptomatic Hyperuricemia with MSUS Changes
NCT04012294Phase 3Unknown
- Sponsor
- Instituto Nacional de Cardiología Ignacio Chávez
- Start
- Aug 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of allopurinol in hyperuricemia, sponsored by Instituto Nacional de Cardiología Ignacio Chávez. Status: unknown.
02
Drugs
allopurinol
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT04012294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04012294.